Literature DB >> 15838800

Inhibition of influenza A virus replication by resveratrol.

Anna T Palamara1, Lucia Nencioni, Katia Aquilano, Giovanna De Chiara, Leyanis Hernandez, Federico Cozzolino, Maria R Ciriolo, Enrico Garaci.   

Abstract

We have previously shown that the life cycles of several viruses are influenced by host-cell redox states. Reports of the antioxidant activities of the plant polyphenol resveratrol (RV) prompted us to investigate its effects on influenza virus replication in vitro and in vivo. We found that RV strongly inhibited the replication of influenza virus in MDCK cells but that this activity was not directly related to glutathione-mediated antioxidant activity. Rather, it involved the blockade of the nuclear-cytoplasmic translocation of viral ribonucleoproteins and reduced expression of late viral proteins seemingly related to the inhibition of protein kinase C activity and its dependent pathways. RV also significantly improved survival and decreased pulmonary viral titers in influenza virus-infected mice. No toxic effects were observed in vitro or in vivo. That RV acts by inhibiting a cellular, rather than a viral, function suggests that it could be a particularly valuable anti-influenza drug.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15838800     DOI: 10.1086/429694

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  76 in total

1.  Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice.

Authors:  Na Zang; Xiaohong Xie; Yu Deng; Shengde Wu; Lijia Wang; Caijing Peng; Simin Li; Ke Ni; Yan Luo; Enmei Liu
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 2.  Role of autophagy in the host response to microbial infection and potential for therapy.

Authors:  Mario Fabri; Susan E Realegeno; Eun-Kyeong Jo; Robert L Modlin
Journal:  Curr Opin Immunol       Date:  2010-11-09       Impact factor: 7.486

Review 3.  Grapevine as a Rich Source of Polyphenolic Compounds.

Authors:  Iva Šikuten; Petra Štambuk; Željko Andabaka; Ivana Tomaz; Zvjezdana Marković; Domagoj Stupić; Edi Maletić; Jasminka Karoglan Kontić; Darko Preiner
Journal:  Molecules       Date:  2020-11-28       Impact factor: 4.411

4.  Grape seed extract for control of human enteric viruses.

Authors:  Xiaowei Su; Doris H D'Souza
Journal:  Appl Environ Microbiol       Date:  2011-04-15       Impact factor: 4.792

Review 5.  Newer influenza antivirals, biotherapeutics and combinations.

Authors:  Frederick G Hayden
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

6.  Role of dietary antioxidants in human metapneumovirus infection.

Authors:  Narayana Komaravelli; John P Kelley; Matteo P Garofalo; Haotian Wu; Antonella Casola; Deepthi Kolli
Journal:  Virus Res       Date:  2015-01-30       Impact factor: 3.303

7.  Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection.

Authors:  Giorgio Conti; Walter Magliani; Stefania Conti; Lucia Nencioni; Rossella Sgarbanti; Anna Teresa Palamara; Luciano Polonelli
Journal:  Antimicrob Agents Chemother       Date:  2008-09-29       Impact factor: 5.191

8.  Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV).

Authors:  Stephan Pleschka; Michael Stein; Roland Schoop; James B Hudson
Journal:  Virol J       Date:  2009-11-13       Impact factor: 4.099

9.  Coming soon to an ICU near you: severe pandemic influenza in ICU patients in Spain.

Authors:  Steven M Opal
Journal:  Crit Care       Date:  2009-10-21       Impact factor: 9.097

10.  Resveratrol exhibits a strong cytotoxic activity in cultured cells and has an antiviral action against polyomavirus: potential clinical use.

Authors:  Valerio Berardi; Francesca Ricci; Mauro Castelli; Gaspare Galati; Gianfranco Risuleo
Journal:  J Exp Clin Cancer Res       Date:  2009-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.